A new JCVI spinout, Diploid Genomics, cofounded by J. Craig Venter, launched with seed funding from Healthier Capital to build an AI‑driven genomics analytics platform for research and diagnostics. The company plans to combine long‑read sequencing technologies, imaging and clinical data to deliver AI‑enhanced diagnostic insights and is pursuing CLIA certification for clinical sequencing services. Diploid intends to offer discovery and diagnostics capabilities that integrate multimodal datasets, positioning itself at the intersection of advanced sequencing, imaging and machine learning. The launch signals continued investor appetite for startups aiming to bundle sequencing with AI analytics and reflects a broader push to commercialize integrated genomics solutions for translational and clinical use.